Literature DB >> 18321783

Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model.

Gopinath S Palanisamy1, Erin E Smith, Crystal A Shanley, Diane J Ordway, Ian M Orme, Randall J Basaraba.   

Abstract

Virulence is the measure of pathogenicity of a microorganism as determined by its ability to invade host tissues and to produce severe disease. In the low-dose aerosol guinea pig model the virulence of multiple strains of Mycobacterium tuberculosis was determined by measuring time of survival, bacterial loads in target organs, and the severity of pulmonary and extra-pulmonary lesions. Erdman K01, CSU93/CDC1551 and HN878 had shorter survival times compared to the common laboratory strain H37Rv. After 30 days of the infection bacilli had disseminated from the lungs resulting in microscopically visible lesions in peribronchial lymph nodes, peripancreatic lymph nodes, spleen, liver, pancreas, adrenal and heart. The extent of the lesion necrosis paralleled virulence when survival times were used as a measure as Erdman K01 and the two clinical isolates caused more necrosis and resulted in sooner death in infected animals than the H37Rv. The extent of extra-pulmonary lesion necrosis was a better predictor of virulence than the number of viable bacilli in the tissue. Overall, this study emphasizes the point that extra-pulmonary disease is a prominent feature of the guinea pig model and dissemination to organs not normally assayed such as the heart and adrenal glands should be taken into account in the assessment of the disease process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321783      PMCID: PMC2572689          DOI: 10.1016/j.tube.2007.12.003

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  25 in total

1.  Virulence of recent notorious Mycobacterium tuberculosis isolates.

Authors:  I M Orme
Journal:  Tuber Lung Dis       Date:  1999

Review 2.  Entry and survival of pathogenic mycobacteria in macrophages.

Authors:  J Pieters
Journal:  Microbes Infect       Date:  2001-03       Impact factor: 2.700

3.  Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis.

Authors:  Claudia Manca; Michael B Reed; Sherry Freeman; Barun Mathema; Barry Kreiswirth; Clifton E Barry; Gilla Kaplan
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

4.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Authors:  C Manca; L Tsenova; A Bergtold; S Freeman; M Tovey; J M Musser; C E Barry; V H Freedman; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 5.  Tuberculosis of the pancreas: report of two cases and review of the literature.

Authors:  Carlos Franco-Paredes; Michael Leonard; Rafael Jurado; Henry M Blumberg; Richard M Smith
Journal:  Am J Med Sci       Date:  2002-01       Impact factor: 2.378

Review 6.  Determinants of vaccine-induced resistance in animal models of pulmonary tuberculosis.

Authors:  D N McMurray
Journal:  Scand J Infect Dis       Date:  2001

7.  Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells.

Authors:  E Martin; A T Kamath; J A Triccas; W J Britton
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Growth of a highly virulent strain of Mycobacterium tuberculosis in mice of differing susceptibility to tuberculous challenge.

Authors:  C L Kelley; F M Collins
Journal:  Tuber Lung Dis       Date:  1999

Review 9.  Diagnosis and management of isolated pancreatic tuberculosis: recent experience and literature review.

Authors:  John C Woodfield; John A Windsor; Catherine C Godfrey; David A Orr; Neil M Officer
Journal:  ANZ J Surg       Date:  2004-05       Impact factor: 1.872

10.  Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

Authors:  Alissa A Chackerian; Jennifer M Alt; Thushara V Perera; Christopher C Dascher; Samuel M Behar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  49 in total

1.  Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.

Authors:  Tuhina Gupta; Monica LaGatta; Shelly Helms; Rebecca L Pavlicek; Simon O Owino; Kaori Sakamoto; Tamas Nagy; Stephen B Harvey; Mark Papania; Stephanie Ledden; Kevin T Schultz; Candace McCombs; Frederick D Quinn; Russell K Karls
Journal:  Tuberculosis (Edinb)       Date:  2018-10-19       Impact factor: 3.131

2.  Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.

Authors:  Mary A De Groote; Veronica Gruppo; Lisa K Woolhiser; Ian M Orme; Janet C Gilliland; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

3.  Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.

Authors:  Andrés Obregón-Henao; Crystal Shanley; María Verónica Bianco; Angel A Cataldi; Randall J Basaraba; Ian M Orme; Fabiana Bigi
Journal:  Vaccine       Date:  2011-04-22       Impact factor: 3.641

4.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

5.  Strain-dependent CNS dissemination in guinea pigs after Mycobacterium tuberculosis aerosol challenge.

Authors:  Nicholas A Be; Lee G Klinkenberg; William R Bishai; Petros C Karakousis; Sanjay K Jain
Journal:  Tuberculosis (Edinb)       Date:  2011-08-09       Impact factor: 3.131

6.  Epidemiologic consequences of microvariation in Mycobacterium tuberculosis.

Authors:  Barun Mathema; Natalia Kurepina; Guibin Yang; Elena Shashkina; Claudia Manca; Carolina Mehaffy; Helle Bielefeldt-Ohmann; Shama Ahuja; Dorothy A Fallows; Angelo Izzo; Pablo Bifani; Karen Dobos; Gilla Kaplan; Barry N Kreiswirth
Journal:  J Infect Dis       Date:  2012-02-07       Impact factor: 5.226

7.  BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity.

Authors:  Andrew Keyser; Jolynn M Troudt; Jennifer L Taylor; Angelo A Izzo
Journal:  Vaccine       Date:  2011-10-18       Impact factor: 3.641

8.  Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells.

Authors:  Diane J Ordway; Shaobin Shang; Marcela Henao-Tamayo; Andres Obregon-Henao; Laura Nold; Megan Caraway; Crystal A Shanley; Randall J Basaraba; Colleen G Duncan; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

Review 9.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

10.  Studies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosis.

Authors:  Katherine C Yam; Igor D'Angelo; Rainer Kalscheuer; Haizhong Zhu; Jian-Xin Wang; Victor Snieckus; Lan H Ly; Paul J Converse; William R Jacobs; Natalie Strynadka; Lindsay D Eltis
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.